Contact Us
Find A Doctor

The MacTel Study Clinical Trial

Enrollment Status



The primary objectives of the MacTel Research Project are to enroll subjects with macular telangiectasia of the group 2 type, to document structural and functional changes, and to follow subjects over a period of up to five (5) years. Data will be analyzed to identify potential risk factors and related outcomes.


Contact Principal Investigator/Coordinator



Contact Us

Dr. Richard Rosen, Principal InvestigatorTel: (212) 979-4284

Katy Tai, Research ManagerTel: (212) 979-4251

Address310 E. 14th StreetNew York, NY 10003

View all locationsContact Us